Article Information
History
- February 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marc-André Legault, B.Sc.a,b,c,
- Johanna Sandoval, M.Sc.a,c,
- Sylvie Provost, M.Sc.a,c,
- Amina Barhdadi, Ph.D.a,c,
- Louis-Philippe Lemieux Perreault, Ph.D.a,c,
- Sonia Shah, Ph.D.d,e,
- R.Thomas Lumbers, Ph.D.f,g,h,
- Simon de Denus, B. Pharm.,Ph.D.a,i,
- Benoit Tyl, M.D.j,
- Jean-Claude Tardif, M.D.*,a,k and
- Marie-Pierre Dubé, Ph.D.*,a,c,k
- AMontreal Heart Institute, Montreal, Canada
- BUniversité de Montréal, Department of biochemistry and molecular medicine, Montreal, Canada
- CUniversité de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montreal, Canada
- DInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
- EInstitute of Cardiovascular Science, University College London, UK
- FInstitute of Health Informatics, University College London, UK
- GHealth Data Research UK London, University College London, UK
- HBart’s Heart Centre, St. Bartholomew’s Hospital, London, UK
- IFaculty of Pharmacy, Université de Montréal, Montreal, Canada
- JCardiovascular Center for Therapeutic Innovation, Institut de Recherches Internationales Servier, Suresnes, France
- KDepartment of medicine, Université de Montréal, Montreal, Canada
- ↵*CORRESPONDING AUTHOR CONTACT INFORMATION
Marie-Pierre Dubé, Montreal Heart Institute, 5000 Belanger Street, Montreal, H1T 1C8, Canada. Tel: 514-376-3330. Fax: 514-593-2521. E-mail: marie-pierre.dube{at}umontreal.ca, Jean-Claude Tardif, Montreal Heart Institute, 5000 Belanger Street, Montreal, H1T 1C8, Canada. Tel: 514-376-3330 ext.3604. Fax: 514 593-2521. E-mail: jean-claude.tardif{at}icm-mhi.org
Posted February 03, 2020.
A genetic model of ivabradine recapitulates results from randomized clinical trials
